QTI - Rega prakiraan analis QT Imaging Holdings

Small-batch device production limits the operating leverage of QT Imaging Holdings, Inc. (QTI), keeping costs high, which constitutes 10.35. The market price shown on this chart serves as a tool for monitoring this process. The business relies on the development of safe 3D ultrasound tomography for breast diagnostics. Meanwhile, the biopharmaceutical sector remains vulnerable due to geopolitical risks and the difficulty of protecting patents under sanctions.

This indicator represents the arithmetic mean of target prices from leading analysts, reflecting institutional expectations of the asset's fair value based on future cash flows. The trend of the weighted average target allows for an assessment of the market premium for the scalability of QT Imaging Holdings, Inc. (QTI), where the integration of AI into cancer diagnostics optimizes operating expenses and expands clinic reach without a linear increase in headcount.